Rocuronium Bromide Injection, Solution
Product Images NDC 0409-5160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 0409-5160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium-spl-carton-100-mg (Rocuronium Spl Carton 100 mg)

Rocuronium-spl-carton-100-mg (Rocuronium Spl Carton 100 mg)
The packaging label for rocuronium bromide injection, solution, 100 mg/10 mL (10 mg/mL) by Hospira, Inc. The box states it contains 10 x 10 mL multiple dose vials for intravenous use only. The label includes warnings of paralyzing agent effects, storage instructions, and notes it is sterile and nonpyrogenic. Distributed by Hospira, Inc., made in India, with a Novaplus logo visible.*
FDA Label Image

Rocuronium-spl-carton-50-mg (Rocuronium Spl Carton 50 mg)

Rocuronium-spl-carton-50-mg (Rocuronium Spl Carton 50 mg)
Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) by Hospira, Inc. The label includes a warning about the drug being a paralyzing agent and specifies it is for intravenous use only. The package contains 10 vials of 5 mL each. Storage instructions and distributor information are also visible on the label.*
FDA Label Image

Rocuronium-spl-fig-1 (Rocuronium Spl Fig 1)

Rocuronium-spl-fig-1 (Rocuronium Spl Fig 1)
A scatter plot with box plots displaying the distribution of a variable measured in minutes across different doses (0.45, 0.9, 1.2 mg/kg) and age groups (18-64 years, ≥65 years, and 1-12 years). The x-axis indicates dose and age category, and the y-axis shows time in minutes.*
FDA Label Image

Rocuronium-spl-fig-2 (Rocuronium Spl Fig 2)

Rocuronium-spl-fig-2 (Rocuronium Spl Fig 2)
A scatter and box plot graph displaying time in minutes on the vertical axis, categorized by various age groups and dosages on the horizontal axis. Data points and box plot summaries vary across categories, illustrating distribution and range without specific numerical labels or titles.*
FDA Label Image

Rocuronium-spl-fig-3 (Rocuronium Spl Fig 3)

Rocuronium-spl-fig-3 (Rocuronium Spl Fig 3)
A line graph showing the relationship between dose number (x-axis, 0 to 6) and time in minutes (y-axis, 0 to 30) for rocuronium bromide. Two lines represent different doses: 0.1 mg/kg and 0.15 mg/kg. Each line shows an increasing trend in minutes with dose number, with data points marked and sample sizes (N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg) indicated.*
FDA Label Image

Rocuronium-spl-fig-4 (Rocuronium Spl Fig 4)

FDA Label Image

Rocuronium-spl-structure (Rocuronium Spl Structure)

Rocuronium-spl-structure (Rocuronium Spl Structure)
Chemical structure of rocuronium bromide, showing the molecular arrangement with a bromide ion (Br-) and characteristic steroidal backbone with functional groups.*
FDA Label Image

Rocuronium-spl-vial-100-mg (Rocuronium Spl Vial 100 mg)

Rocuronium-spl-vial-100-mg (Rocuronium Spl Vial 100 mg)
Label for Rocuronium Bromide Injection 10 mg/mL in a 10 mL multiple-dose vial. This sterile, nonpyrogenic intravenous solution is labeled as a paralyzing agent and includes warnings about respiratory arrest and storage instructions. Distributed by Hospira, Inc., with a distinctive Novaplus logo, the label features dosage, usage, and storage details, along with barcode and lot information fields.*
FDA Label Image

Rocuronium-spl-vial-50-mg (Rocuronium Spl Vial 50 mg)

Rocuronium-spl-vial-50-mg (Rocuronium Spl Vial 50 mg)
Label for Rocuronium Bromide Injection, 10 mg/mL (50 mg/5 mL) multiple dose vial by Hospira, Inc. The label highlights it is a sterile, nonpyrogenic intravenous injection with warnings about its paralyzing effects and respiratory arrest risk. Storage instructions and distributor information are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.